Viridian Therapeutics (UK) Analysis
| 0K1R Stock | 21.01 0.98 4.89% |
Viridian Therapeutics is overvalued with Real Value of 17.39 and Hype Value of 21.8. The main objective of Viridian Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Viridian Therapeutics is worth, separate from its market price. There are two main types of Viridian Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Viridian Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Viridian Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Viridian Therapeutics stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Viridian Therapeutics is usually not traded on Spring Bank Holiday ( 2024 ), Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday. Viridian Stock trading window is adjusted to Europe/London timezone.
Viridian |
Viridian Stock Analysis Notes
About 100.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 5.14. Viridian Therapeutics had not issued any dividends in recent years. The entity had 0.066667:1 split on the 13th of November 2020. For more info on Viridian Therapeutics please contact MBA JD at 617 272 4600 or go to https://www.viridiantherapeutics.com.Viridian Therapeutics Quarterly Total Revenue |
|
Viridian Therapeutics Investment Alerts
| Viridian Therapeutics is way too risky over 90 days horizon | |
| Viridian Therapeutics appears to be risky and price may revert if volatility continues | |
| Viridian Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 314 K. Net Loss for the year was (237.73 M) with loss before overhead, payroll, taxes, and interest of (99.12 M). | |
| Viridian Therapeutics generates negative cash flow from operations | |
| Latest headline from news.google.com: Principal Financial Group Inc. Buys 162,665 Shares of Viridian Therapeutics, Inc. - MarketBeat |
Viridian Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.84 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viridian Therapeutics's market, we take the total number of its shares issued and multiply it by Viridian Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Management Efficiency
Viridian Therapeutics has return on total asset (ROA) of (0.3215) % which means that it has lost $0.3215 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5188) %, meaning that it generated substantial loss on money invested by shareholders. Viridian Therapeutics' management efficiency ratios could be used to measure how well Viridian Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Viridian Therapeutics' Total Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 1 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 2.5 M in 2024.Leadership effectiveness at Viridian Therapeutics is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (970.70) | Beta 1.114 | Return On Assets (0.32) | Return On Equity (0.52) |
Technical Drivers
As of the 26th of November, Viridian Therapeutics has the Semi Deviation of 3.37, coefficient of variation of 814.68, and Risk Adjusted Performance of 0.1023. Viridian Therapeutics technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Viridian Therapeutics variance, jensen alpha, and the relationship between the standard deviation and information ratio to decide if Viridian Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 21.01 per share.Viridian Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Viridian Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Viridian Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Viridian Therapeutics Predictive Daily Indicators
Viridian Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Viridian Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Viridian Therapeutics Forecast Models
Viridian Therapeutics' time-series forecasting models are one of many Viridian Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viridian Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Viridian Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Viridian Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viridian shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Viridian Therapeutics. By using and applying Viridian Stock analysis, traders can create a robust methodology for identifying Viridian entry and exit points for their positions.
Viridian Therapeutics is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Viridian Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Additional Tools for Viridian Stock Analysis
When running Viridian Therapeutics' price analysis, check to measure Viridian Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viridian Therapeutics is operating at the current time. Most of Viridian Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viridian Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viridian Therapeutics' price. Additionally, you may evaluate how the addition of Viridian Therapeutics to your portfolios can decrease your overall portfolio volatility.